Skip to main content

Table 6 Cytotoxicity of OJS in various cell lines

From: Cytotoxicity and sub-acute toxicity in Crl:CD (SD) rats of traditional herbal formula Ojeok-san

Cell line

Origin

Concentration (μg/ml)

0

10

20

50

100

200

SH-SY5Y

Human, Neuroblastoma

100 ± 1.97

100 ± 3.48

99 ± 1.74

99 ± 3.34

98 ± 2.65

96 ± 1.55

Clone M-3

Mouse, Melanoma

100 ± 4.22

101 ± 5.59

98 ± 3.67

100 ± 8.26

99 ± 6.17

99 ± 10.22

SK-N-SH

Human, Neuroblastoma (brain)

100 ± 2.20

105 ± 2.71

104 ± 1.66

107 ± 3.00

105 ± 1.38

108 ± 3.09

U-373 MG

Human, Glioblastoma (brain)

100 ± 2.63

100 ± 4.28

97 ± 1.83

95 ± 1.44

96 ± 1.67

96 ± 4.22

U-87 MG

Human, Glioblastoma (brain)

100 ± 7.07

100 ± 2.56

96 ± 1.22

99 ± 4.13

100 ± 3.38

100 ± 4.74

HEK-293

Human, Kidney

100 ± 9.45

101 ± 3.50

109 ± 4.62

106 ± 3.60

96 ± 2.86

97 ± 3.14

HepG2

Human, Hepatoblastoma

100 ± 2.67

92 ± 3.49

93 ± 3.05

92 ± 4.92

99 ± 2.06

87 ± 4.32

Hep3B

Human, Hepatocarcinoma

100 ± 1.95

100 ± 2.56

101 ± 2.15

104 ± 0.51

96 ± 3.47

93 ± 0.85

RAW 264.7

Mouse, Macrophage

100 ± 5.72

112 ± 9.54

121 ± 3.42

117 ± 3.59

115 ± 1.71

113 ± 1.56

3T3-L1

Mouse, Fibroblast (pre-adipocyte)

100 ± 2.60

105 ± 3.71

105 ± 2.67

110 ± 1.95

109 ± 3.04

113 ± 4.31

HIT-T15

Hamster, Pancreas

100 ± 2.83

95 ± 15.62

97 ± 13.85

97 ± 16.78

96 ± 8.35

95 ± 7.53

HL-60

Human, Leukemia, lymphoblast

100 ± 1.13

100 ± 1.25

100 ± 1.50

99 ± 1.43

100 ± 1.97

98 ± 1.99

HT-29

Human, Colon cancer cell

100 ± 2.78

102 ± 1.36

121 ± 2.55

99 ± 1.79

102 ± 3.45

104 ± 4.85

NIH-3T3

Mouse, Fibroblast

100 ± 6.28

102 ± 5.43

103 ± 5.32

102 ± 6.82

105 ± 9.97

104 ± 5.99

B16F10

Mouse, Melanoma

100 ± 8.87

91 ± 2.43

91 ± 5.50

94 ± 3.17

98 ± 6.68

111 ± 3.72

MCF-7

Human, Breast cancer

100 ± 4.84

114 ± 11.1

114 ± 0.44

114 ± 4.23

110 ± 8.76

110 ± 4.33

HaCaT

Human, Keratinocyte

100 ± 1.55

98 ± 1.67

98 ± 1.00

99 ± 3.21

97 ± 3.81

102 ± 2.99

PC12

Rat, Adrenal medulla, pheochromocytoma

100 ± 1.28

102 ± 1.71

96 ± 1.54

98 ± 2.94

98 ± 2.12

93 ± 3.20

AGS

Human, Gastric adenocarcinoma

100 ± 1.31

99 ± 1.94

100 ± 3.8

94 ± 10.36

96 ± 1.83

100 ± 1.80

BEAS-2B

Human, Bronchial epithelial, normal cell

100 ± 2.00

102 ± 0.86

101 ± 1.24

101 ± 0.65

104 ± 3.42

105 ± 2.68

LNCaP

Human, Prostate cancer

100 ± 9.14

101 ± 5.75

102 ± 8.88

101 ± 7.03

102 ± 12.51

98 ± 6.86

RBL-1

Rat, Basophilic leukemia

100 ± 5.97

102 ± 9.42

102 ± 6.60

102 ± 1.80

103 ± 2.12

102 ± 0.58

NRK52

Rat, Kidney

100 ± 1.19

100 ± 1.19

99 ± 2.18

102 ± 1.01

102 ± 3.99

106 ± 2.65